McLaughlin, T. et al. 2025. Adverse Events Reported Following RSV Prefusion F Protein Vaccines Administration Among Approved Populations: A Cross-Sectional Study. Kansas Journal of Medicine. 18, 6 (Dec. 2025), 129–133. DOI:https://doi.org/10.17161/kjm.vol18.23980.